The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 43, Issue 5, 2013, Pages 915-918

  Maeyashiki, Tatsuo ^a   Suzuki, Kenji ^a   Hattori, Aritoshi ^a   Matsunaga, Takeshi ^a   Takamochi, Kazuya ^a   Oh, Shiaki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Computed tomography; Consolidation; Lung cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BRONCHOGRAPHY; CANCER STAGING; CANCER SURVIVAL; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84876877542     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs516     Document Type: Article

References (18)

1. Aoki T, Tomoda Y, Watanabe H, Nakata H, Kasai T, Hashimoto H et al. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001;220: 803-9.
2. Takamochi K, Nagai K, Yoshida J, Suzuki K, Ohde Y, Nishimura M et al. Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings. J Thorac Cardiovasc Surg 2001;122:325-30.
3. Suzuki K, Asamura H, Kusumoto M, Kondo H, Tsuchiya R. "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002;74: 1635-9.
4. Suzuki K, Yokose T, Yoshida J, Nishimura M, Takahashi K, Nagai K et al. Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. Ann Thorac Surg 2000;69:893-7.
5. Suzuki K, Koike T, Asakawa T, Kusumoto M, Asamura H, Nagai K et al. A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol 2011;6: 751-6.
6. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-22; discussion 622-613.
7. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1978;76:832-9.
8. Kodama K, Higashiyama M, Yokouchi H, Takami K, Kuriyama K, Mano M et al. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 2001;33: 17-25.
9. Maeshima AM, Tochigi N, Yoshida A, Asamura H, Tsuta K, Tsuda H. Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator. J Thorac Oncol 2010;5:333-9.
10. Suzuki K, Kusumoto M, Watanabe S, Tsuchiya R, Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg 2006;81:413-9.
11. Inoue M, Minami M, Sawabata N, Utsumi T, Kadota Y, Shigemura N et al. Clinical outcome of resected solid-type small-sized c-stage IA nonsmall cell lung cancer. Eur J Cardiothorac Surg 2010;37:1445-9.
12. Ohtaki Y, Yoshida J, Ishii G, Aokage K, Hishida T, Nishimura M et al. Prognostic significance of a solid component in pulmonary adenocarcinoma. Ann Thorac Surg 2011;91:1051-7.
13. Tsubota N, Ayabe K, Doi O, Mori T, Namikawa S, Taki T et al. Ongoing prospective study of segmentectomy for small lung tumors. Study Group of Extended Segmentectomy for Small Lung Tumor. Ann Thorac Surg 1998;66:1787-90.
14. Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 2006;132:769-75.
15. Yoshino I, Ichinose Y, Nagashima A, Takeo S, Motohiro A, Yano T et al. Clinical characterization of node-negative lung adenocarcinoma: results of a prospective investigation. J Thorac Oncol 2006;1:825-31.
16. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011;6: 244-85.
17. Warth A, Muley T, Meister M, Stenzinger A, Thomas M, Schirmacher P et al. The novel histologic international association for the study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 2012;30:1438-46.
18. Shim HS, Lee da H, Park EJ, Kim SH. Histopathologic characteristics of lung adenocarcinomas with epidermal growth factor receptor mutations in the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification. Arch Pathol Lab Med 2011;135:1329-34.